tradingkey.logo

ASX-listed Xero unlikely to improve US prospects post-Melio acquisition, Morningstar says

ReutersSep 14, 2025 11:11 PM

** Morningstar trims fair value estimate for Xero XRO.AX by 2% to A$100, citing material overvaluation

** Morningstar also notes a sizable fall in co's stock price after the announcement of the acquisition of U.S. fintech firm Melio Payments

** Xero is nearing market saturation in Australia and New Zealand, as evidenced by fast-deteriorating returns on sales and marketing spending there, Morningstar says

** Investment research firm expects fewer resources for more "winnable" international markets, given co’s heavy focus on the "unwinnable" U.S. market

** Adds that Melio's buyout will not materially improve co’s conversion or retention of customers

** 11 of 14 analysts rate the stock "buy" or higher, three rate "hold"; their median price target is A$205, per data compiled by LSEG

** Stock is down 3.9% YTD as of last close

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

Tradingkey
KeyAI